FDA Approves Inhaled Insulin for Diabetes
HealthScout - SATURDAY, Jan. 28 (HealthDay News) -- Exubera, the first inhaled insulin treatment for diabetes, won approval from U.S. regulatory officials on Friday. The long-awaited action by the U.S. Food and Drug Administration means millions of people with

0 Comments:
Post a Comment
<< Home